Genome Research | Health Newstrack

Largest human cancer genome data released in US

World’s largest release of comprehensive human cancer genome data helps speed discoveries — Whole genome data from hundreds of St. Jude Children’s Research Hospital patients exceeds volume of all other sources combined – A comprehensive human cancer genome data is released in US for free access by the global scientific community. The amount of information released more than doubles the volume of high-coverage, whole genome data currently available from all human genome sources combined.

Whole genome breast cancer study launched by Mayo Clinic USA

Mayo Clinic launches whole genome breast cancer study – The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

Leprosy susceptibility genes reported in a genome study

Leprosy susceptibility genes reported in New England Journal of Medicine paper — Largest genome-wide association study of an infectious disease – In the first genome-wide association study (GWAS) of leprosy and the largest GWAS on an infectious disease, scientists at the Genome Institute of Singapore (GIS) and 26 institutes in China identified seven genes that increase an individual’s susceptibility to leprosy.

Human Genome Sequencing decoded in India

CSIR completes first ever Human Genome Sequencing in India – The Council of Scientific and Industrial Research (CSIR) has achieved completion of first ever Human Genome Sequencing in India. Scientist of CSIR at the Institute of Genomics and Integrative Biology (IGIB), Delhi have sequenced the Human Genome of an anonymous healthy Indian citizen.

Genome 10K – to sequence 10000 vertebrates

‘Genome 10K’ proposal aims to sequence 10,000 vertebrates – An international group of scientists is proposing to generate whole genome sequences for 10,000 vertebrate species using technology so new it hasn’t yet been invented.

Researchers decoded genetic evolution of a breast cancer tumour

Major breast cancer breakthrough announced at BC Cancer Agency — BC scientists first in world to decode genetic evolution of a breast cancer tumour. – Canadian researchers have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumor, a type of breast cancer which accounts for about 10 per cent of all breast cancers.

Schistosomiasis parasite’s Schistosoma mansoni’s Genome decoded

Scientists decode genome of deadly parasitic worm — Schistosoma mansoni — that causes intestinal schistosomiasis. – Researchers have sequenced the genome of the parasite — Schistosoma mansoni — that causes intestinal schistosomiasis (also known as bilharzia or snail fever), a devastating tropical disease that afflicts more than 200 million people in the developing world.

$24 million for rare and neglected diseases research

NIH announces new program to develop therapeutics for rare and neglected diseases – The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases Program, or TRND.

Draft version of the Neanderthal genome completed

The Max Planck Institute for Evolutionary Anthropology and 454 Life Sciences Corp. have completed a draft sequence of the Neandertal genome – The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, and the 454 Life Sciences Corporation, in Branford, Connecticut, will announce on 12 February during the 2009 Annual Meeting of the American Association for the Advancement of Science (AAAS) and at a simultaneous European press briefing that they have completed a first draft version of the Neandertal genome.

International Cancer Genome Consortium sets sights on cancer

Researchers from four continents announced the launch of the International Cancer Genome Consortium (ICGC), a major collaboration designed to identify the key genetic mutations involved in up to 50 types of cancer. – The International Cancer Genome Consortium (ICGC), which includes the Wellcome Trust and the Wellcome Trust Sanger Institute in the UK, will generate a valuable resource enabling the development of new and better ways of diagnosing, treating and preventing cancer.